Femasys Inc
NASDAQ:FEMY
Femasys Inc
Depreciation & Amortization
Femasys Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Femasys Inc
NASDAQ:FEMY
|
Depreciation & Amortization
$483.5k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Depreciation & Amortization
$1.2B
|
CAGR 3-Years
66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Depreciation & Amortization
$1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
Abbott Laboratories
NYSE:ABT
|
Depreciation & Amortization
$3.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Depreciation & Amortization
$472.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
21%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Depreciation & Amortization
$11.8m
|
CAGR 3-Years
75%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
See Also
What is Femasys Inc's Depreciation & Amortization?
Depreciation & Amortization
483.5k
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Depreciation & Amortization amounts to 483.5k USD.
What is Femasys Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-11%
Over the last year, the Depreciation & Amortization growth was -14%. The average annual Depreciation & Amortization growth rates for Femasys Inc have been -11% over the past three years .